ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yasuharu Imai
Yoshinori Takanashi
Makoto Nakazawa
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hiramatsu, T.
Right arrow Articles by Nakazawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hiramatsu, T.
Right arrow Articles by Nakazawa, M.

Ann Thorac Surg 1999;68:169-172
© 1999 The Society of Thoracic Surgeons


Original Articles

Time course of endothelin-1 and adrenomedullin after the Fontan procedure

Takeshi Hiramatsu, MDa, Yasuharu Imai, MDa, Yoshinori Takanashi, MDa, Kazuhiro Seo, MDa, Masatsugu Terada, MDa, Mitsuru Aoki, MDa, Makoto Nakazawa, MDb

a Department of Pediatric Cardiac Surgery, Tokyo Women’s Medical University, Heart Institute of Japan, Tokyo, Japan
b Department of Cardiology, Tokyo Women’s Medical University, Heart Institute of Japan, Tokyo, Japan

Address reprint requests to Dr Hiramatsu, Department of Pediatric Cardiac Surgery, Tokyo Women’s Medical University, Heart Institute of Japan, 8-1, Shinjuku-ku, Tokyo, 162-8666 Japan

Background. The endothelium-derived vasoconstrictor endothelin (ET)-1 might contribute to the physiology of blood flow regulation and play a role in cardiovascular disease. Adrenomedullin (AM) is a potent vasodilator peptide that has major effects on cardiovascular function and has multiple biologic effects involved in cardiovascular homeostasis. Although pulmonary vascular resistance is known to be one of the most important factors to determine the indications for a Fontan procedure, the time course of the plasma cytokine before and after the Fontan procedure is not known.

Methods. Sixteen patients were divided into two groups, 8 patients (1 to 14 years) who had the Fontan procedure (atriopulmonary connection) and 8 age-matched controls who had biventricular repair with normal central venous pressure. Plasma ET-1 and adrenomedullin levels were measured in both groups immediately before cardiopulmonary bypass, immediately after cardiopulmonary bypass, and 6 and 24 hours after cardiopulmonary bypass. A thermodilution catheter was inserted during the operation, and mean pulmonary arterial pressure, pulmonary wedge pressure, and cardiac output were measured, and pulmonary vascular resistance was calculated at the same time points. Correlation between the plasma ET-1 levels and pulmonary vascular resistance data were obtained in the Fontan group.

Results. Plasma ET-1 levels in the Fontan group were elevated after operation and were higher than the control group at 6 and 24 hours after cardiopulmonary bypass. Plasma adrenomedullin in the Fontan group was lower than in the control group at 6 and 24 hours after cardiopulmonary bypass. A significant positive correlation was obtained between the plasma ET-1 and pulmonary vascular resistance data (r = 0.475).

Conclusions. Imbalance between increased ET-1 and relatively decreased adrenomedullin after cardiopulmonary bypass in the Fontan procedure could contribute to dominant effects of ET-1, which might induce vasoconstriction after the Fontan procedure. ET-1 might play an important role in maintaining vasoconstriction after the Fontan procedure.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
D. Yoshikawa, F. Kawahara, N. Okano, H. Hiraoka, Y. Kadoi, N. Fujita, T. Morita, and F. Goto
Increased Plasma Concentrations of the Mature Form of Adrenomedullin During Cardiac Surgery and Hepatosplanchnic Hypoperfusion
Anesth. Analg., September 1, 2003; 97(3): 663 - 670.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Hiramatsu, Y. Imai, H. Kurosawa, Y. Takanashi, M. Aoki, T. Shin'oka, and M. Nakazawa
Effects of dilutional and modified ultrafiltration in plasma endothelin-1 and pulmonary vascular resistance after the Fontan procedure
Ann. Thorac. Surg., March 1, 2002; 73(3): 862 - 865.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. H. Dorman, R. B. New, B. R. Bond, R. Mukherjee, Y. V. Mukhin, J. H. McElmurray, and F. G. Spinale
Myocyte Endothelin Exposure During Cardioplegic Arrest Exacerbates Contractile Dysfunction After Reperfusion
Anesth. Analg., May 1, 2000; 90(5): 1080 - 1085.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.